These new medications, like copyright and Semaglutide, represent a significant class of drugs called GLP-1 receptor mimics. This class of medications work by increasing the body's intrinsic ability to secrete GLP-1, a hormone that helps control blood sugar and food intake. Originally, designed for managing type 2 diabetes, this treatment have in ad

Sufferers struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, Wegovy, is rapidly changing the landscape of weight loss. Utilized by regulatory bodies for chronic weight management, Semaglutide acts as a glucagon-like peptide-1 (GLP-1) receptor agonist. This pro